b 213 750 (Niacin Extended-Release 750 mg)

Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; niacin deficiency; pellagra and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 213 750

Save up to 80% off prescription medications

Click here for your free Discount Card

Niacin Extended-Release

Imprint

b 213 750

Strength

750 mg

Color

White

Shape

Capsule-shape

Availability

Rx and/or OTC

Drug Class

Miscellaneous antihyperlipidemic agents, Vitamins

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Teva Pharmaceuticals USA Inc.

National Drug Code (NDC)

00093-7393

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer